+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bioactive Peptides Market by Type, Source, Type, Production Process, Function, Formulation, Sales Channel, Application - Global Forecast to 2030- Product Image
Bioactive Peptides Market by Type, Source, Type, Production Process, Function, Formulation, Sales Channel, Application - Global Forecast to 2030- Product Image
Sale

Bioactive Peptides Market by Type, Source, Type, Production Process, Function, Formulation, Sales Channel, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 199 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6055466
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bioactive Peptides Market grew from USD 4.74 billion in 2024 to USD 5.15 billion in 2025. It is expected to continue growing at a CAGR of 8.84%, reaching USD 7.88 billion by 2030.

Navigating the Rise of Bioactive Peptides with Strategic Clarity

Bioactive peptides have emerged as a transformative force across nutraceuticals, functional foods, pharmaceuticals and cosmetics, offering targeted health benefits that range from blood pressure modulation to immune support. These short chains of amino acids, produced through enzymatic hydrolysis, fermentation or synthetic routes, exhibit potent biological activities in human physiology when administered at effective doses. As consumer demand escalates for science-backed ingredients that deliver measurable health outcomes, bioactive peptides have secured a central role in product innovation and formulation strategies.

This executive summary distills key findings from a rigorous market analysis that examines technological advancements, shifting regulatory landscapes and evolving competitive dynamics. By synthesizing segmentation insights-across source, molecular type, production process, functional application, formulation and sales channels-this study equips industry leaders with a nuanced understanding of emerging growth pockets. We also assess the cumulative impact of new tariff measures in the United States and offer regional perspectives spanning the Americas, Europe, Middle East & Africa and Asia-Pacific. Grounded in both primary stakeholder interviews and secondary database research, this summary lays the groundwork for actionable strategies that drive market penetration and sustainable expansion.

Transformative Shifts Reshaping the Bioactive Peptides Landscape

Over the past five years, the bioactive peptides landscape has undergone transformative shifts driven by advances in precision hydrolysis, recombinant expression technologies and high-throughput screening platforms. Companies are leveraging proprietary enzyme processes and fermentation strains to enhance yield, reduce production costs and tailor peptide profiles to specific health endpoints. At the same time, regulatory agencies are increasingly endorsing peptide-based claims, streamlining approval pathways while tightening safety and purity requirements to protect consumer health.

Concurrently, strategic collaborations between ingredient suppliers, contract manufacturers and research institutions have accelerated product development cycles. Digital tools for in silico peptide design and predictive modeling have further optimized discovery and formulation workflows. As sustainability concerns intensify, firms are adopting circular bioeconomy principles, sourcing underutilized by-products and minimizing waste streams. These converging trends are redefining competitive advantages in the market, elevating speed to market, regulatory agility and evidence-based marketing as essential differentiators.

Assessing the Cumulative Impact of 2025 US Tariffs on Peptide Trade

Effective January 2025, the United States implemented a series of additional import tariffs targeting key raw materials and intermediate ingredients used in peptide production. These measures have elevated landed costs for animal-derived proteins such as dairy and egg whites, as well as for specialty enzymes sourced via microbial fermentation. Manufacturers dependent on cross-border supply chains have absorbed increased expenses or passed them onto customers, creating pricing pressures across nutraceutical, pharmaceutical and cosmetic channels.

In response, forward-looking organizations have diversified procurement by tapping alternative suppliers in Asia-Pacific and Europe, negotiating long-term contracts to stabilize input costs. Some have reshored portions of enzymatic hydrolysis operations to mitigate tariff exposure, investing in local capacity expansions. Meanwhile, partnerships with synthetic biology firms have gained traction as a means of bypassing tariff-impacted feedstocks and achieving consistent peptide profiles. Taken together, these strategic adjustments underscore the market’s adaptability in the face of evolving trade policies.

Deep-Dive Segmentation Unveils Nuanced Market Dynamics

A granular view of market segmentation reveals a mosaic of opportunities and competitive battles. When analyzed by peptide origin, the endogenous category-naturally occurring sequences released during protein breakdown-captures significant attention for its inherent biocompatibility, whereas exogenous peptides, delivered as isolated ingredients, dominate dietary supplement formulations. Examining source, animal-derived proteins such as dairy isolates, egg white fractions, marine extracts and meat-derived peptides continue to command premium pricing, while microbial fermentation routes offer scalable economies and plant-based sources like pea, rice and soy peptides address the growing vegan and clean-label demand alongside fully synthetic analogues.

Turning to molecular architecture, dipeptides and tripeptides exhibit superior absorption profiles, oligomeric chains balance functionality with cost, and polypeptides serve niche applications requiring sustained release. Production pathways vary from traditional chemical synthesis to enzymatic hydrolysis, fermentation processes and recombinant expression, each bringing unique cost structures and purity benchmarks. Functional applications span cardiovascular health through antihypertensive activity, microbiome support via antimicrobial effects, oxidative stress mitigation with antioxidants and immune modulation to suit personalized nutrition trends.

Formulation preferences shift based on delivery mode: capsules lead due to consumer familiarity, liquids cater to pediatric and geriatric segments, and powders enable high-dose flexibility. Sales channels split between established offline networks-health specialty stores and pharmacies-and burgeoning online platforms, inclusive of brand-owned websites and third-party e-commerce marketplaces. Application domains range from cosmeceuticals leveraging antioxidant peptides, through functional foods fortified with digestive enzymes, to nutraceuticals and prescription pharmaceuticals targeting metabolic and inflammatory conditions.

Regional Dynamics Driving Bioactive Peptide Adoption Worldwide

Regional dynamics shape growth trajectories as companies navigate distinct regulatory frameworks and consumer landscapes. In the Americas, robust demand for evidence-based supplements and stringent FDA oversight drive high-quality standards, positioning the United States as both a leading market and an innovation hub. Canada’s expanding functional food sector further bolsters regional momentum. Across Europe, Middle East & Africa, harmonized EU regulations grant access to a massive consumer base while individual country markets in Germany, France and the Gulf Cooperation Council present differentiated opportunities based on dietary preferences and healthcare guidelines.

Meanwhile, Asia-Pacific stands out as the fastest-growing region, propelled by expanding middle-class income levels, government support for biotechnology manufacturing and large-scale fermentation capacity expansions in China and India. Japan’s mature nutraceutical market values premium peptide extracts, while Southeast Asian nations harness local agricultural by-products to develop cost-competitive offerings. These region-specific factors underscore the importance of adaptive go-to-market approaches and targeted investments to capitalize on evolving consumer demands and policy environments.

Top Industry Players Charting the Future of Bioactive Peptides

Industry leaders are actively refining their portfolios to maintain technological leadership and satisfy diverse end-market needs. Major integrators of dairy- and egg-derived peptides are forging alliances with biotech startups to co-develop enzyme platforms, while established fermentation specialists are scaling up microbial systems to yield plant-based peptides at commercial volumes. Synthetic biology pioneers are focusing on custom peptide libraries for precision-targeted health applications, positioning themselves as strategic partners for CPG and pharmaceutical brands seeking novel active ingredients.

Meanwhile, contract manufacturing organizations are investing in state-of-the-art purification and encapsulation facilities to meet stringent GMP requirements and cater to high-purity niches. Several companies have prioritized comprehensive quality management systems and secured ISO and HACCP certifications to reinforce trust among global customers. Across the board, M&A activity and cross-border joint ventures remain robust as firms seek to consolidate supply chains, expand geographic reach and accelerate product pipelines with proven bioactive sequences.

Actionable Strategies for Industry Leaders to Capitalize on Growth

To thrive in this dynamic environment, industry leaders must sharpen their focus on integrated innovation roadmaps. Prioritizing modular production platforms that seamlessly switch between enzymatic, fermentation and recombinant processes will safeguard against raw material disruptions and tariff shifts. Concurrently, investing in advanced analytics for in silico peptide design can shorten discovery timelines and unlock tailored health benefit claims. Organizations should also deepen collaboration with regulatory bodies to anticipate evolving compliance requirements and fast-track dossier approvals.

On the commercial front, omnichannel distribution strategies blending digital direct-to-consumer engagement with traditional retail partnerships will maximize market coverage. Crafting targeted formulations geared toward emerging consumer segments-such as active aging, sports nutrition and pediatric wellness-will differentiate product offerings. Moreover, embedding sustainability metrics into sourcing, production and packaging protocols will resonate with environmentally conscious buyers and enhance brand equity. By executing these initiatives in lockstep, companies can secure competitive advantages and drive long-term revenue growth.

Rigorous Research Methodology Ensuring Unbiased Insights

This study combines primary interviews with senior executives from peptide manufacturers, CPG brands, contract research organizations and regulatory consultants alongside secondary data culled from industry journals, patent filings, trade association reports and public financial filings. Quantitative analyses were validated through cross-verification of import-export logs, production capacity disclosures and consumption trends published by global health authorities.

Throughout the research process, a structured quality assurance framework was applied, including peer review by independent experts, consistency checks against historical benchmarks and reconciliation of conflicting data points. Segmentation definitions were iteratively refined in collaboration with sector specialists to ensure alignment with real-world commercial practices. This rigorous methodology underpins the credibility and objectivity of the insights presented in this executive summary and the accompanying detailed report.

Synthesizing Insights to Navigate the Bioactive Peptides Frontier

In summary, the bioactive peptides sector stands at the intersection of cutting-edge science and growing health consciousness. Technological advancements in extraction and synthesis, together with supportive regulatory shifts and evolving consumer expectations, have charted a clear path for innovation. Tariff-related challenges in the United States are prompting strategic supply chain realignments, while regional nuances across the Americas, EMEA and Asia-Pacific offer differentiated opportunities for targeted expansion.

Segmentation analysis underscores the diverse value propositions linked to peptide origin, molecular structure, production technology, function and delivery format. Key players are capitalizing on these insights through partnerships, capacity investments and quality certifications. For decision-makers, the imperative is clear: harness robust research, embrace adaptive production strategies and deliver scientifically validated formulations that resonate with end consumers. This cohesive approach will unlock new revenue streams and solidify leadership positions in a rapidly evolving marketplace.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Type
    • Endogenous
    • Exogenous
  • Source
    • Animal Derived
      • Dairy Proteins
      • Egg White Proteins
      • Marine Proteins
      • Meat Proteins
    • Microbial Fermentation
    • Plant-Based
      • Pea
      • Rice
      • Soy
    • Synthetic
  • Type
    • Dipeptide
    • Oligopeptide
    • Polypeptide
    • Tripeptide
  • Production Process
    • Chemical Synthesis
    • Enzymatic Hydrolysis
    • Fermentation
    • Recombinant Production
  • Function
    • Antihypertensive
    • Antimicrobial
    • Antioxidant
    • Immunomodulatory
  • Formulation
    • Capsule
    • Liquid
    • Powder
  • Sales Channel
    • Offline
    • Online
      • Brand Websites
      • E-Commerce Websites
  • Application
    • Cosmetics
    • Functional Foods
    • Nutraceuticals
    • Pharmaceuticals
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Abbott Laboratories
  • Ajinomoto Co., Inc.
  • Amgen Inc.
  • Archer Daniels Midland Company
  • Ashland Inc.
  • Bachem Holding AG
  • BASF SE
  • Clariant AG
  • CPC Scientific Inc.
  • Croda International Plc
  • Eli Lilly and Company
  • Evonik Industries AG
  • Ferring Pharmaceuticals Pvt. Ltd.
  • GenScript Biotech Corporation
  • Givaudan SA
  • Glanbia plc
  • Koninklijke DSM N.V.
  • LipoTrue SL
  • Lonza Group
  • Merck & Co., Inc.
  • Novo Nordisk A/S
  • Novozymes A/S
  • PeptiDream Inc.
  • Pfizer Inc.
  • PolyPeptide Group AG
  • Protagonist Therapeutics, Inc.
  • Symrise AG
  • Zealand Pharma A/S

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bioactive Peptides Market, by Type
8.1. Introduction
8.2. Endogenous
8.3. Exogenous
9. Bioactive Peptides Market, by Source
9.1. Introduction
9.2. Animal Derived
9.2.1. Dairy Proteins
9.2.2. Egg White Proteins
9.2.3. Marine Proteins
9.2.4. Meat Proteins
9.3. Microbial Fermentation
9.4. Plant-Based
9.4.1. Pea
9.4.2. Rice
9.4.3. Soy
9.5. Synthetic
10. Bioactive Peptides Market, by Type
10.1. Introduction
10.2. Dipeptide
10.3. Oligopeptide
10.4. Polypeptide
10.5. Tripeptide
11. Bioactive Peptides Market, by Production Process
11.1. Introduction
11.2. Chemical Synthesis
11.3. Enzymatic Hydrolysis
11.4. Fermentation
11.5. Recombinant Production
12. Bioactive Peptides Market, by Function
12.1. Introduction
12.2. Antihypertensive
12.3. Antimicrobial
12.4. Antioxidant
12.5. Immunomodulatory
13. Bioactive Peptides Market, by Formulation
13.1. Introduction
13.2. Capsule
13.3. Liquid
13.4. Powder
14. Bioactive Peptides Market, by Sales Channel
14.1. Introduction
14.2. Offline
14.3. Online
14.3.1. Brand Websites
14.3.2. E-Commerce Websites
15. Bioactive Peptides Market, by Application
15.1. Introduction
15.2. Cosmetics
15.3. Functional Foods
15.4. Nutraceuticals
15.5. Pharmaceuticals
16. Americas Bioactive Peptides Market
16.1. Introduction
16.2. Argentina
16.3. Brazil
16.4. Canada
16.5. Mexico
16.6. United States
17. Asia-Pacific Bioactive Peptides Market
17.1. Introduction
17.2. Australia
17.3. China
17.4. India
17.5. Indonesia
17.6. Japan
17.7. Malaysia
17.8. Philippines
17.9. Singapore
17.10. South Korea
17.11. Taiwan
17.12. Thailand
17.13. Vietnam
18. Europe, Middle East & Africa Bioactive Peptides Market
18.1. Introduction
18.2. Denmark
18.3. Egypt
18.4. Finland
18.5. France
18.6. Germany
18.7. Israel
18.8. Italy
18.9. Netherlands
18.10. Nigeria
18.11. Norway
18.12. Poland
18.13. Qatar
18.14. Russia
18.15. Saudi Arabia
18.16. South Africa
18.17. Spain
18.18. Sweden
18.19. Switzerland
18.20. Turkey
18.21. United Arab Emirates
18.22. United Kingdom
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. Abbott Laboratories
19.3.2. Ajinomoto Co., Inc.
19.3.3. Amgen Inc.
19.3.4. Archer Daniels Midland Company
19.3.5. Ashland Inc.
19.3.6. Bachem Holding AG
19.3.7. BASF SE
19.3.8. Clariant AG
19.3.9. CPC Scientific Inc.
19.3.10. Croda International Plc
19.3.11. Eli Lilly and Company
19.3.12. Evonik Industries AG
19.3.13. Ferring Pharmaceuticals Pvt. Ltd.
19.3.14. GenScript Biotech Corporation
19.3.15. Givaudan SA
19.3.16. Glanbia plc
19.3.17. Koninklijke DSM N.V.
19.3.18. LipoTrue SL
19.3.19. Lonza Group
19.3.20. Merck & Co., Inc.
19.3.21. Novo Nordisk A/S
19.3.22. Novozymes A/S
19.3.23. PeptiDream Inc.
19.3.24. Pfizer Inc.
19.3.25. PolyPeptide Group AG
19.3.26. Protagonist Therapeutics, Inc.
19.3.27. Symrise AG
19.3.28. Zealand Pharma A/S
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. BIOACTIVE PEPTIDES MARKET MULTI-CURRENCY
FIGURE 2. BIOACTIVE PEPTIDES MARKET MULTI-LANGUAGE
FIGURE 3. BIOACTIVE PEPTIDES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2024 VS 2030 (%)
FIGURE 20. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 22. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 26. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. BIOACTIVE PEPTIDES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 32. BIOACTIVE PEPTIDES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOACTIVE PEPTIDES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY ENDOGENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY EXOGENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY DAIRY PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY EGG WHITE PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY MARINE PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY MEAT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY MICROBIAL FERMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY PEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY RICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY SOY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY DIPEPTIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY OLIGOPEPTIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY POLYPEPTIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY TRIPEPTIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY ENZYMATIC HYDROLYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY FERMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY RECOMBINANT PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY ANTIHYPERTENSIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY ANTIMICROBIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY ANTIOXIDANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY IMMUNOMODULATORY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY BRAND WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY E-COMMERCE WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY COSMETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTIONAL FOODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY NUTRACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. CANADA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. CANADA BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 89. CANADA BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 90. CANADA BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 91. CANADA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. CANADA BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 93. CANADA BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 94. CANADA BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 95. CANADA BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. CANADA BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 97. CANADA BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. MEXICO BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. MEXICO BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 100. MEXICO BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 101. MEXICO BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 102. MEXICO BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. MEXICO BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 104. MEXICO BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 105. MEXICO BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 106. MEXICO BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. MEXICO BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 108. MEXICO BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 124. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 126. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 127. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 128. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 129. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 133. AUSTRALIA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. AUSTRALIA BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 135. AUSTRALIA BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 136. AUSTRALIA BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 137. AUSTRALIA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. AUSTRALIA BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 139. AUSTRALIA BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 140. AUSTRALIA BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 141. AUSTRALIA BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. AUSTRALIA BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 143. AUSTRALIA BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. CHINA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 145. CHINA BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 146. CHINA BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 147. CHINA BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 148. CHINA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 149. CHINA BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 150. CHINA BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 151. CHINA BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 152. CHINA BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. CHINA BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 154. CHINA BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. INDIA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 156. INDIA BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 157. INDIA BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 158. INDIA BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 159. INDIA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 160. INDIA BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 161. INDIA BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 162. INDIA BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 163. INDIA BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. INDIA BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 165. INDIA BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. INDONESIA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 167. INDONESIA BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 168. INDONESIA BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 169. INDONESIA BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 170. INDONESIA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 171. INDONESIA BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 172. INDONESIA BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 173. INDONESIA BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 174. INDONESIA BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. INDONESIA BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 176. INDONESIA BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. JAPAN BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 178. JAPAN BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 179. JAPAN BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 180. JAPAN BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 181. JAPAN BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 182. JAPAN BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 183. JAPAN BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 184. JAPAN BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 185. JAPAN BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. JAPAN BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 187. JAPAN BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. MALAYSIA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 189. MALAYSIA BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 190. MALAYSIA BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 191. MALAYSIA BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 192. MALAYSIA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 193. MALAYSIA BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 194. MALAYSIA BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 195. MALAYSIA BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 196. MALAYSIA BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. MALAYSIA BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 198. MALAYSIA BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. PHILIPPINES BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 200. PHILIPPINES BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 201. PHILIPPINES BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 202. PHILIPPINES BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 203. PHILIPPINES BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 204. PHILIPPINES BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 205. PHILIPPINES BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 206. PHILIPPINES BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 207. PHILIPPINES BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. PHILIPPINES BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 209. PHILIPPINES BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. SINGAPORE BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 211. SINGAPORE BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 212. SINGAPORE BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 213. SINGAPORE BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 214. SINGAPORE BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 215. SINGAPORE BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 216. SINGAPORE BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 217. SINGAPORE BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 218. SINGAPORE BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 219. SINGAPORE BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 220. SINGAPORE BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. SOUTH KOREA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 222. SOUTH KOREA BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 223. SOUTH KOREA BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 224. SOUTH KOREA BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 225. SOUTH KOREA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 226. SOUTH KOREA BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 227. SOUTH KOREA BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 228. SOUTH KOREA BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 229. SOUTH KOREA BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 230. SOUTH KOREA BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 231. SOUTH KOREA BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. TAIWAN BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 233. TAIWAN BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 234. TAIWAN BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 235. TAIWAN BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 236. TAIWAN BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 237. TAIWAN BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 238. TAIWAN BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 239. TAIWAN BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 240. TAIWAN BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 241. TAIWAN BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 242. TAIWAN BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. THAILAND BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 244. THAILAND BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 245. THAILAND BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 246. THAILAND BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 247. THAILAND BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 248. THAILAND BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 249. THAILAND BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 250. THAILAND BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 251. THAILAND BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. THAILAND BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 253. THAILAND BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. VIETNAM BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 255. VIETNAM BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 256. VIETNAM BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 257. VIETNAM BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 258. VIETNAM BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 259. VIETNAM BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 260. VIETNAM BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 261. VIETNAM BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 262. VIETNAM BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 263. VIETNAM BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 264. VIETNAM BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 277. DENMARK BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 278. DENMARK BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 279. DENMARK BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 280. DENMARK BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 281. DENMARK BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 282. DENMARK BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 283. DENMARK BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 284. DENMARK BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 285. DENMARK BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 286. DENMARK BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 287. DENMARK BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 288. EGYPT BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 289. EGYPT BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 290. EGYPT BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 291. EGYPT BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 292. EGYPT BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 293. EGYPT BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 294. EGYPT BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 295. EGYPT BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 296. EGYPT BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 297. EGYPT BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 298. EGYPT BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 299. FINLAND BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 300. FINLAND BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 301. FINLAND BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 302. FINLAND BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 303. FINLAND BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 304. FINLAND BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 305. FINLAND BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 306. FINLAND BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 307. FINLAND BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 308. FINLAND BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 309. FINLAND BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 310. FRANCE BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 311. FRANCE BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 312. FRANCE BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 313. FRANCE BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 314. FRANCE BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 315. FRANCE BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 316. FRANCE BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 317. FRANCE BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 318. FRANCE BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 319. FRANCE BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 320. FRANCE BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 321. GERMANY BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 322. GERMANY BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 323. GERMANY BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 324. GERMANY BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 325. GERMANY BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 326. GERMANY BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 327. GERMANY BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 328. GERMANY BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 329. GERMANY BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 330. GERMANY BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 331. GERMANY BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 332. ISRAEL BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 333. ISRAEL BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 334. ISRAEL BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 335. ISRAEL BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 336. ISRAEL BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 337. ISRAEL BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 338. ISRAEL BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 339. ISRAEL BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 340. ISRAEL BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 341. ISRAEL BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 342. ISRAEL BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 343. ITALY BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 344. ITALY BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 345. ITALY BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 346. ITALY BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 347. ITALY BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 348. ITALY BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
TABLE 349. ITALY BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 350. ITALY BIOACTIVE PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 351. ITALY BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 352. ITALY BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 353. ITALY BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 354. NETHERLANDS BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 355. NETHERLANDS BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 356. NETHERLANDS BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, 2018-2030 (USD MILLION)
TABLE 357. NETHERLANDS BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
TABLE 358. NETHERLANDS BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 359. NETHE

Companies Mentioned

The companies profiled in this Bioactive Peptides market report include:
  • Abbott Laboratories
  • Ajinomoto Co., Inc.
  • Amgen Inc.
  • Archer Daniels Midland Company
  • Ashland Inc.
  • Bachem Holding AG
  • BASF SE
  • Clariant AG
  • CPC Scientific Inc.
  • Croda International Plc
  • Eli Lilly and Company
  • Evonik Industries AG
  • Ferring Pharmaceuticals Pvt. Ltd.
  • GenScript Biotech Corporation
  • Givaudan SA
  • Glanbia plc
  • Koninklijke DSM N.V.
  • LipoTrue SL
  • Lonza Group
  • Merck & Co., Inc.
  • Novo Nordisk A/S
  • Novozymes A/S
  • PeptiDream Inc.
  • Pfizer Inc.
  • PolyPeptide Group AG
  • Protagonist Therapeutics, Inc.
  • Symrise AG
  • Zealand Pharma A/S

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages199
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5.15 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.88 Billion
Compound Annual Growth Rate8.8%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

2025 Bioactive Protein and Peptides Market Report - Industry Size, Competition, Trends and Growth Opportunities by Region - Forecast by Types and Applications (2024-2032) - Product Image

2025 Bioactive Protein and Peptides Market Report - Industry Size, Competition, Trends and Growth Opportunities by Region - Forecast by Types and Applications (2024-2032)

  • Report
  • 144 Pages
  • Global
From
Bioactive Wound Healing Dressings Market by Product Type, Material Composition, Application, End User, Distribution Channel - Global Forecast to 2030 - Product Image

Bioactive Wound Healing Dressings Market by Product Type, Material Composition, Application, End User, Distribution Channel - Global Forecast to 2030

  • Report
  • 193 Pages
  • Global
From
2025 Bioactive Proteins In Coffee Market Report - Industry Size, Competition, Trends and Growth Opportunities by Region - Forecast by Types and Applications (2024-2032) - Product Image

2025 Bioactive Proteins In Coffee Market Report - Industry Size, Competition, Trends and Growth Opportunities by Region - Forecast by Types and Applications (2024-2032)

  • Report
  • 146 Pages
  • Global
From
Bioactive Dressings Market by Product Type, Application, End User, Distribution Channel, Technology - Global Forecast to 2030 - Product Image

Bioactive Dressings Market by Product Type, Application, End User, Distribution Channel, Technology - Global Forecast to 2030

  • Report
  • 198 Pages
  • Global
From
Bioactive Wound Care Market Size, Share & Trends Analysis Report By Product (Moist, Antimicrobial, Active Dressing), By Application (General Surgery, Minimally invasive Surgery), By Region, And Segments Forecasts, 2024 - 2030 - Product Image

Bioactive Wound Care Market Size, Share & Trends Analysis Report By Product (Moist, Antimicrobial, Active Dressing), By Application (General Surgery, Minimally invasive Surgery), By Region, And Segments Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.